Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis

Journal of Clinical Immunology

Volumn 30, Issue 4, 2010, Pages 566-573

  Jiang, Jing ^a,b   Wang, Xianyuan ^a,b   Wang, Xinjing ^b   Cao, Zhihong ^b   Liu, Yanhua ^b   Dong, Mei ^b   Tong, Aihua ^b   Cheng, Xiaoxing ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Biomarker; CD27; CD4+ T cells; Persistent infection; Tuberculosis

Indexed keywords

CD27 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; KI 67 ANTIGEN; BIOLOGICAL MARKER; T LYMPHOCYTE RECEPTOR; TUBERCULIN;

ADULT; AGE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIUM CULTURE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LUNG CAVITY; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL; SPUTUM CULTURE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSIENT EXPRESSION; TUBERCULIN TEST; TUBERCULOUS PLEURISY; CASE CONTROL STUDY; DEFICIENCY; IMMUNOLOGY; MIDDLE AGED; MYCOBACTERIUM; TUBERCULOSIS; YOUNG ADULT;

ADULT; ANTIGENS, CD27; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM; T-CELL ANTIGEN RECEPTOR SPECIFICITY; TUBERCULIN; TUBERCULOSIS; YOUNG ADULT;

EID: 77956267096     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9418-1     Document Type: Article

References (32)

1. WHO. Global tuberculosis control: epidemiology, strategy, financing. 2009.
2. Korbel DS, Schneider BE, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 2008;10:995-1004.
3. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb). 2003;83:98-106.
4. Nolte MA, van Olffen RW, van Gisbergen KP, van Lier RA. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev. 2009;229:216-31.
5. Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17:275-81.
6. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000;1:433-40.
7. Bowman MR, Crimmins MA, Yetz-Aldape J, Kriz R, Kelleher K, Herrmann S. The cloning of CD70 and its identification as the ligand for CD27. J Immunol. 1994;152:1756-61.
8. Hintzen RQ, Lens SM, Beckmann MP, Goodwin RG, Lynch D, van Lier RA. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol. 1994;152:1762-73.
9. Tesselaar K, Xiao Y, Arens R, van Schijndel GM, Schuurhuis DH, Mebius RE, et al. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol. 2003;170:33-40.
10. Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun. N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem. 1998;273:13353-8.
11. Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, Pals ST, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgammamediated B cell depletion. Immunity. 2001;15:801-12.
12. Kapina MA, Shepelkova GS, Mischenko VV, Sayles P, Bogacheva P, Winslow G, et al. CD27 low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ, produce IFN-gamma, and protect the host against tuberculosis infection. J Immunol. 2007;178:976-85.
13. Streitz M, Tesfa L, Yildirim V, Yahyazadeh A, Ulrichs T, Lenkei R, et al. Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis. PLoS One. 2007;2: e735.
14. Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med. 2005;11:1113-7.
15. Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M, et al. Direct access to CD4+ Tcells specific for defined antigens according to CD154 expression. Nat Med. 2005;11:1118-24.
16. Kirchhoff D, Frentsch M, Leclerk P, Bumann D, Rausch S, Hartmann S, et al. Identification and isolation of murine antigenreactive T cells according to CD154 expression. Eur J Immunol. 2007;37:2370-7.
17. Wang X, Cao Z, Jiang J, Niu H, Dong M, Tong A, et al. Association of mycobacterial antigen-specific CD4 (+) memory T cell subsets with outcome of pulmonary tuberculosis. J Infect. 2010;60:133-9.
18. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-5.
19. Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis. 2009;9:162-72.
20. Doherty M, Wallis RS, Zumla A. Biomarkers for tuberculosis disease status and diagnosis. Curr Opin Pulm Med. 2009;15:181-7.
21. Dooms H, Abbas AK. Control of CD4+ T-cell memory by cytokines and costimulators. Immunol Rev. 2006;211:23-38.
22. De Jong R, Brouwer M, Hooibrink B, Van der Pouw-Kraan T, Miedema F, Van Lier RA. The CD27-subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol. 1992;22:993-9.
23. Ochsenbein AF, Riddell SR, Brown M, Corey L, Baerlocher GM, Lansdorp PM, et al. CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J Exp Med. 2004;200:1407-17.
24. Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol. 2008;20:1189-99.
25. Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, et al. Transcriptional repressor Blimp-1 promotes CD8 (+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity. 2009;31:296-308.
26. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997;186:1407-18.
27. Takata H, Takiguchi M. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol. 2006;177:4330-40.
28. Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, Lipsky PE. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol. 2005;175:6489-97.
29. De Milito A, Aleman S, Marenzi R, Sonnerborg A, Fuchs D, Zazzi M, et al. Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. Clin Exp Immunol. 2002;127:486-94.
30. Yoshida H, Maeda T, Ishikawa J, Inoue S, Matsunaga H, Kosugi S, et al. Expression of CD27 on peripheral CD4+ T-lymphocytes correlates with the development of severe acute graft-versus-host disease after allogeneic bone marrow transplantation. Int J Hematol. 2006;84:367-76.
31. Lyadova IV, Oberdorf S, Kapina MA, Apt AS, Swain SL, Sayles PC. CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype. Clin Exp Immunol. 2004;138:21-9.
32. Stubbe M, Vanderheyde N, Goldman M, Marchant A. Antigenspecific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J Immunol. 2006;177:8185-90.